Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Hozumi Kumagai"'
Autor:
Hozumi Kumagai, Kenta Nio, Yuta Okumura, Masato Komoda, Tsuyoshi Shirakawa, Hitoshi Kusaba, Shioto Yasuda, Keita Odashiro, Shuji Arita, Hiroshi Ariyama, Yuichi Yamada, Hidetaka Yamamoto, Yoshinao Oda, Katsumasa Nakamura, Koichi Akashi, Eishi Baba
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 2, Pp 484-490 (2014)
Undifferentiated malignant neoplasms, which occur primarily in the pulmonary artery, are extremely rare and associated with poor outcomes as there is no effective therapy. A 67-year-old woman visited our hospital with complaints of dry cough and dysp
Externí odkaz:
https://doaj.org/article/b6db90169f9f4deabf8e81bb6dc7deec
Autor:
Toshiaki Saito, Mototsugu Shimokawa, Takako Shimada, Takahiro Kogawa, Hozumi Kumagai, Masafumi Ohki, Tsunehisa Kaku
Publikováno v:
Journal of Cancer
Purpose: A growing number of treatment options and active compounds in treatments have led to better outcomes for patients with advanced or recurrent epithelial ovarian cancer. We examined the association between progression-free survival (PFS), post
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14aacebc304e216b44c784641a0ba7bd
http://europepmc.org/articles/PMC5868151
http://europepmc.org/articles/PMC5868151
Autor:
Shingo Tamura, Shuji Arita, Yoshihiro Shibata, Keita Uchino, Kenta Nio, Koichi Akashi, Hitoshi Kusaba, Eishi Baba, Hozumi Kumagai, Michitaka Nakano, Keita Odashiro, Tsuyoshi Shirakawa, Hiroshi Ariyama, Masato Komoda
Publikováno v:
Anti-Cancer Drugs. 27:891-898
Appropriate management of cardiovascular diseases (CVDs) related to chemotherapy for solid tumors is important for safe oncologic treatment. However, prediction of the onset and progression of CVDs has not generally been established in Japan. We carr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01efe278a1b6f03ab7bda60c54b00e7f
https://doi.org/10.1097/cad.0000000000000392
https://doi.org/10.1097/cad.0000000000000392
Autor:
Yoshinao Oda, Hiroshi Ariyama, Taito Esaki, Tsuyoshi Shirakawa, Shuntaro Nagai, Kenji Mitsugi, Hitoshi Kusaba, Koichi Akashi, Hozumi Kumagai, Tatsuya Manabe, Motohiro Esaki, Shuji Arita, Daijiro Higashi, Takashi Ueki, Kitaro Futami, Yoshihiro Shibata, Minako Hirahashi, Eishi Baba, Michitaka Nakano, Koji Nakashima, Kenta Nio
Publikováno v:
Anti-Cancer Drugs. 27:457-463
Chemotherapy for advanced colitis-associated colorectal cancer (CAC) has been insufficiently evaluated. The goal of this study was to clarify the efficacy and safety of chemotherapy for CAC in Japan. CAC patients who were treated with chemotherapy be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da0ece86598430cfcdbc7d11d6f9dc9
https://doi.org/10.1097/cad.0000000000000338
https://doi.org/10.1097/cad.0000000000000338
Autor:
KYOKO INADOMI1, HOZUMI KUMAGAI1, KOTOE TAKAYOSHI1, HIROSHI ARIYAMA1, HITOSHI KUSABA1, AKIHIRO NISHIE2, HIDETAKA YAMAMOTO3, KEN TAKASE4, MAMORU TANAKA1, KOSUKE SAGARA1, YUTA OKUMURA1, KENTA NIO1, MICHITAKA NAKANO1, SHUJI ARITA1, YOSHINAO ODA3, KOICHI AKASHI1, EISHI BABA5 e-baba@intmed1.med.kyushu-u.ac.jp
Publikováno v:
Oncology Letters. Nov2015, Vol. 10 Issue 5, p2981-2985. 5p.
Autor:
Kenji Mitsugi, Takeharu Yamanaka, Koichi Akashi, Akitaka Makiyama, Hitoshi Kusaba, Chinatsu Makiyama, Kotoe Takayoshi, Kenta Nio, Eishi Baba, Hozumi Kumagai, Yoshihiro Shibata, Tsuyoshi Shirakawa, Hiroshi Ariyama, Taito Esaki, Kyoko Inadomi, Shingo Tamura, Mamoru Ito, Gen Hirano
Publikováno v:
Medicine
Purpose: Combination therapy of fosaprepitant, dexamethasone (DEX) and a serotonin (5-HT3) receptor antagonist is a standard antiemetic prophylaxis for patients receiving highly emetogenic chemotherapy (HEC). However, the appropriate dose of DEX has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05eb60bed1f6b7372c953ffa9c88c26a
http://europepmc.org/articles/PMC6023705
http://europepmc.org/articles/PMC6023705
Autor:
Shioto Yasuda, Hozumi Kumagai, Hitoshi Kusaba, Yuichi Yamada, Hiroshi Ariyama, Katsumasa Nakamura, Eishi Baba, Masato Komoda, Tsuyoshi Shirakawa, Kenta Nio, Shuji Arita, Yuta Okumura, Hidetaka Yamamoto, Keita Odashiro, Yoshinao Oda, Koichi Akashi
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 7, Iss 2, Pp 484-490 (2014)
Case Reports in Oncology, Vol 7, Iss 2, Pp 484-490 (2014)
Undifferentiated malignant neoplasms, which occur primarily in the pulmonary artery, are extremely rare and associated with poor outcomes as there is no effective therapy. A 67-year-old woman visited our hospital with complaints of dry cough and dysp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de74d6af006f3d96fef086fbf4813bc9
http://europepmc.org/articles/PMC4154194
http://europepmc.org/articles/PMC4154194
Autor:
Yuta Okumura, Shigeo Takaishi, Hiroshi Ariyama, Mayako Uchida, Hozumi Kumagai, Koichi Akashi, Michitaka Nakano, Kenichiro Nagata, Hitoshi Kusaba, Shingo Tamura, Shuji Arita, Masato Komoda, Eishi Baba
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:461-465
Background: Antiemetic triplet therapy including dexamethasone (DEX) is widely used for patients receiving highly emetogenic chemotherapy (HEC). In Japan, the appropriate dose of DEX has not been established for this combination. Materials and Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4504aae7bc96f1d942751ae97eb8ee59
https://doi.org/10.7314/apjcp.2014.15.1.461
https://doi.org/10.7314/apjcp.2014.15.1.461
Autor:
Kyoko Inadomi, Tomoya Matsunobu, Hozumi Kumagai, Katsumi Harimaya, Eishi Baba, Hitoshi Kusaba, Kotoe Takayoshi, Hiroshi Ariyama, Koichi Akashi, Shuji Arita
Publikováno v:
Medicine
Appropriate antiemetic prophylaxis for moderately emetogenic chemotherapy in patients with non-round cell soft-tissue sarcomas (NRC-STS) remains unclear. We retrospectively investigated efficacy and safety of aprepitant-combined antiemetic prophylaxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a77841b9893a469821dfa7ff13514eb
https://pubmed.ncbi.nlm.nih.gov/27930525
https://pubmed.ncbi.nlm.nih.gov/27930525
Autor:
Hiroshi Ariyama, Hitoshi Kusaba, Tsuyoshi Shirakawa, Masato Komoda, Yuta Okumura, Hozumi Kumagai, Takayuki Matsumoto, Eishi Baba, Hidetaka Yamamoto, Yoshinao Oda, Junji Umeno, Koichi Akashi, Shingo Tamura, Shuji Arita
Publikováno v:
International Cancer Conference Journal. 3:165-168
Peutz-Jeghers syndrome (PJS) is an autosomal dominant genetic syndrome characterized by gastrointestinal hamartomatous polyposis. Malignant transformation of the polyp is rare, but the incidence of various cancers, including digestive organ cancers,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c9d43c409008963a2f265f198ca43d9
https://doi.org/10.1007/s13691-013-0139-1
https://doi.org/10.1007/s13691-013-0139-1